Table 3.
Association of TGFβ responses with tumor progression and recurrence.
| Tumor | Type | TGFb activation class |
| MIXED III 886 | Primary | Weak |
| GBM 1463 | Recurrent | Weak |
| OLIGO III 975 | Primary | Weak |
| GBM 1028 | Recurrent | Weak |
| OLIGO III 744 | Primary | Weak |
| GBM 996 | Recurrent | Strong |
| OLIGO III 840 | Primary | Weak |
| GBM 1334 | Recurrent | Strong |
| GBM 938 | Primary | Weak |
| GBM 1406 | Recurrent | Strong |
| GBM 2028 | Primary | Weak |
| GBM 2029 | Primary | Weak |
| GBM 2067 | Recurrent | Strong |
| GBM 2068 | Recurrent | Weak |
Primary and recurrent tumors from the same patient were grouped together.